Keyphrases
Adult Patients
100%
Acute Respiratory Distress Syndrome
100%
Phase II Trial
100%
Partial Liquid Ventilation
100%
Gas Exchange
50%
FiO2
33%
Extracorporeal Life Support
33%
Severe Respiratory Failure
16%
Hypoxia
16%
Intratracheal
16%
Adverse Events
16%
Total Dose
16%
Hemodynamic Parameters
16%
Hyperbilirubinemia
16%
PaO2
16%
Pulmonary Hemodynamics
16%
Pulmonary Compliance
16%
SvO2
16%
Perflubron
16%
First-year Experience
16%
Severe Adverse Effects
16%
INIS
patients
100%
adults
100%
liquids
100%
ventilation
100%
gases
37%
data
25%
safety
25%
doses
12%
failures
12%
compliance
12%
hypoxia
12%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Adult Respiratory Distress Syndrome
100%
Hypoxia
50%
Respiratory Failure
50%
Hyperbilirubinemia
50%
Perfluorooctyl Bromide
50%